Indeed, regarding intranasal vaccination against PI3, BRSV and IBR, Olivett et al. demonstrated that while an intranasal vaccination protocol did not affect the occurrence of abnormal respiratory scores, it did reduce the risk of lung lesions associated with pneumonia (33). This evidence concerns the gene PI3 and pneumonia.